MedMesh.i
Corpus
PubMed
Racine
Corpus
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

Le SIDA en Afrique subsaharienne (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « HIV Protease Inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
HIV Protease < HIV Protease Inhibitors < HIV Reverse Transcriptase  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000150 (2010) Halimatou Diop-Ndiaye ; Coumba Toure-Kane ; Nafissatou Leye ; Ndeye Fatou Ngom-Gueye ; Céline Montavon ; Martine Peeters ; Souleymane MboupAntiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal.
000289 (2010) Julia Drylewicz ; Serge Eholie ; Moussa Maiga ; Djimon Marcel Zannou ; Papa Salif Sow ; Didier K. Ekouevi ; Kevin Peterson ; Emmanuel Bissagnene ; François Dabis ; Rodolphe ThiébautFirst-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration.
000435 (2010) Doaa Elsherbiny ; Yuan Ren ; Helen Mcilleron ; Gary Maartens ; Ulrika S H. SimonssonPopulation pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children.
000780 (2017) Burger Symington ; Rudo F. Mapanga ; Gavin R. Norton ; M Faadiel EssopResveratrol Co-Treatment Attenuates the Effects of HIV Protease Inhibitors on Rat Body Weight and Enhances Cardiac Mitochondrial Respiration.
000A89 (2017) Dami Collier ; Collins Iwuji ; Anne Derache ; Tulio De Oliveira ; Nonhlanhla Okesola ; Alexandra Calmy ; Francois Dabis ; Deenan Pillay ; Ravindra K. GuptaVirological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
000A97 (2017) Mark A. Boyd ; Janaki Amin ; Patrick W G. Mallon ; Nagalingeswaran Kumarasamy ; Johan Lombaard ; Robin Wood ; Ploenchan Chetchotisakd ; Praphan Phanuphak ; Lerato Mohapi ; Iskandar Azwa ; Waldo H. Belloso ; Jean-Michel Molina ; Jennifer Hoy ; Cecilia L. Moore ; Sean Emery ; David A. CooperBody composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
001082 (2013) Karen Schneider ; Chidi Nwizu ; Richard Kaplan ; Jonathan Anderson ; David P. Wilson ; Sean Emery ; David A. Cooper ; Mark A. BoydThe potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa.
001349 (2014) Gbenga Anthony Adefolaju ; Kathrine Elizabeth Theron ; Margot Jill HosieEffects of HIV protease, nucleoside/non-nucleoside reverse transcriptase inhibitors on Bax, Bcl-2 and apoptosis in two cervical cell lines.
001386 (2013) Allison Martin ; Cecilia Moore ; Patrick W G. Mallon ; Jennifer Hoy ; Sean Emery ; Waldo Belloso ; Praphan Phanuphak ; Samuel Ferret ; David A. Cooper ; Mark A. BoydBone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy.
001504 (2013) Petrina Kapewangolo ; Ahmed A. Hussein ; Debra MeyerInhibition of HIV-1 enzymes, antioxidant and anti-inflammatory activities of Plectranthus barbatus.
001563 (2014) Kathleen M S E. Reyskens ; M Faadiel EssopHIV protease inhibitors and onset of cardiovascular diseases: a central role for oxidative stress and dysregulation of the ubiquitin-proteasome system.
001631 (2013) Kathleen M S E. Reyskens ; M Faadiel EssopThe maladaptive effects of HIV protease inhibitors (lopinavir/ritonavir) on the rat heart.
001634 (2013) Kathleen M S E. Reyskens ; Tarryn-Lee Fisher ; Jonathan C. Schisler ; Wendi G. O'Connor ; Arlin B. Rogers ; Monte S. Willis ; Cynthia Planesse ; Florence Boyer ; Philippe Rondeau ; Emmanuel Bourdon ; M Faadiel EssopCardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "HIV Protease Inhibitors" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "HIV Protease Inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    HIV Protease Inhibitors
}}
Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024